skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101 (Code C99168)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101

Definition: A radioimmunoconjugate composed of a humanized monoclonal antibody (MoAb) OTSA101 against FZD10 and labeled with yttrium y 90, with potential antineoplastic activity. The MoAb moiety of yttrium Y 90-labeled anti-FZD10 monoclonal antibody OTSA101 binds to FZD10, thereby delivering a cytotoxic dose of beta radiation to FZD10 positive tumor cells. FZD10 (also called CD350), a member of the Frizzled family of G protein-coupled receptors that is involved in the Wnt/beta-catenin/TCF signaling pathway, is overexpressed in a variety of cancer cell types but undetectable in normal, healthy human tissues except for the placenta.

Label: Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101

NCI Thesaurus Code: C99168 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL433017  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101

External Source Codes: 
PDQ Closed Trial Search ID 717536
PDQ Open Trial Search ID 717536 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C99168
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom